SubHero Banner
Text

Bafiertam(monomethyl fumarate) – New drug approval

April 28, 2020 - The FDA approved Banner Life Sciences’ Bafiertam (monomethyl fumarate), for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Download PDF